234 related articles for article (PubMed ID: 28366792)
1. Serum macrophage migration inhibitory factor concentrations correlate with prognosis of traumatic brain injury.
Yang DB; Yu WH; Dong XQ; Zhang ZY; Du Q; Zhu Q; Che ZH; Wang H; Shen YF; Jiang L
Clin Chim Acta; 2017 Jun; 469():99-104. PubMed ID: 28366792
[TBL] [Abstract][Full Text] [Related]
2. Serum thioredoxin and in-hospital major adverse events after traumatic brain injury.
Dong XQ; Yu WH; Zhang ZY; Yang DB; Du Q; Wang H; Shen YF; Jiang L; Che ZH; Zhu Q
Clin Chim Acta; 2017 Jun; 469():75-80. PubMed ID: 28347674
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of plasma nesfatin-1 concentrations in patients with traumatic brain injury.
Wu GQ; Chou XM; Ji WJ; Yang XG; Lan LX; Sheng YJ; Shen YF; Li JR; Huang GZ; Yu WH; Dong XQ; Du Q; Yang DB; Zhang ZY; Wang H; Shen YF; Jiang L
Clin Chim Acta; 2016 Jul; 458():124-8. PubMed ID: 27155585
[TBL] [Abstract][Full Text] [Related]
4. Serum S100A12 as a prognostic biomarker of severe traumatic brain injury.
Feng MJ; Ning WB; Wang W; Lv ZH; Liu XB; Zhu Y; Gao W; Jin HZ; Gao SS
Clin Chim Acta; 2018 May; 480():84-91. PubMed ID: 29408171
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor as a serum prognostic marker in patients with aneurysmal subarachnoid hemorrhage.
Chen YH; Cheng ZY; Shao LH; Shentu HS; Fu B
Clin Chim Acta; 2017 Oct; 473():60-64. PubMed ID: 28823650
[TBL] [Abstract][Full Text] [Related]
6. Serum ST2 as a potential prognostic biomarker for traumatic brain injury.
Du Q; Weng JF; Luo LF; Cen M; Yu WH; Zheng YK; Hu W; Pan JW; Dong XQ
Clin Chim Acta; 2018 Dec; 487():145-152. PubMed ID: 30266513
[TBL] [Abstract][Full Text] [Related]
7. The change of plasma galectin-3 concentrations after traumatic brain injury.
Shen YF; Yu WH; Dong XQ; Du Q; Yang DB; Wu GQ; Zhang ZY; Wang H; Jiang L
Clin Chim Acta; 2016 May; 456():75-80. PubMed ID: 26944570
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of serum translocator protein in patients with traumatic brain injury.
Luo LF; Weng JF; Cen M; Dong XQ; Yu WH; Du Q; Yang DB; Zheng YK; Hu W; Yu L; Luo SD
Clin Chim Acta; 2019 Jan; 488():25-30. PubMed ID: 30385279
[TBL] [Abstract][Full Text] [Related]
9. Correlation of tenascin-C concentrations in serum with outcome of traumatic brain injury in humans.
Zhao YY; Lou L; Yang KC; Wang HB; Xu Y; Lu G; He HY
Clin Chim Acta; 2017 Sep; 472():46-50. PubMed ID: 28732652
[TBL] [Abstract][Full Text] [Related]
10. The 90-day prognostic value of serum cyclophilin A in traumatic brain injury.
Jin HH; Mao TM; Bai ZQ; Chen Y; Ji HL; Jin Y
Clin Chim Acta; 2018 Sep; 484():258-264. PubMed ID: 29885319
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of serum interleukin-33 as a prognostic marker of severe traumatic brain injury.
Zhang ZY; Li J; Ye Q; Dong Y; Bao GM; Shen YK; Weng JF; Luo LF; Cen M
Clin Chim Acta; 2019 Oct; 497():6-12. PubMed ID: 31279693
[TBL] [Abstract][Full Text] [Related]
12. Retrospective study on the correlation between serum MIF level and the condition and prognosis of patients with traumatic head injury.
Liu Z; Liu C; Ma K
PeerJ; 2023; 11():e15933. PubMed ID: 37645013
[TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor levels in serum from patients with acute intracerebral hemorrhage: Potential contribution to prognosis.
Lin Q; Cai JY; Lu C; Sun J; Ba HJ; Chen MH; Chen XD; Dai JX; Lin JH
Clin Chim Acta; 2017 Sep; 472():58-63. PubMed ID: 28729134
[TBL] [Abstract][Full Text] [Related]
14. Serum CXC chemokine ligand-12 as a potential predictor for in-hospital major adverse events after severe traumatic brain injury.
Shen LJ; Zhou J; Yang CS; Lv QW; Xu QC
Clin Chim Acta; 2020 Oct; 509():244-248. PubMed ID: 32569633
[TBL] [Abstract][Full Text] [Related]
15. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
[TBL] [Abstract][Full Text] [Related]
16. Pilot study: elevated circulating levels of the proinflammatory cytokine macrophage migration inhibitory factor in patients with chronic spinal cord injury.
Stein A; Panjwani A; Sison C; Rosen L; Chugh R; Metz C; Bank M; Bloom O
Arch Phys Med Rehabil; 2013 Aug; 94(8):1498-507. PubMed ID: 23618747
[TBL] [Abstract][Full Text] [Related]
17. Utility of serum macrophage migration inhibitory factor as a potential biomarker for detection of cerebrocardiac syndrome following severe traumatic brain injury.
Dai JX; Lin Q; Ba HJ; Ye LZ; Li ZW; Cai JY
Clin Chim Acta; 2021 Jan; 512():179-184. PubMed ID: 33181151
[TBL] [Abstract][Full Text] [Related]
18. Role of signal peptide-Cub-Egf domain-containing protein-1 in serum as a predictive biomarker of outcome after severe traumatic brain injury.
Chen QH; Lin D; Zhou J; Deng G
Clin Chim Acta; 2016 May; 456():63-66. PubMed ID: 26940951
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of serum macrophage migration inhibitory factor levels in pulmonary tuberculosis.
Wang Q; Han W; Niu J; Sun B; Dong W; Li G
Respir Res; 2019 Mar; 20(1):50. PubMed ID: 30841876
[TBL] [Abstract][Full Text] [Related]
20. Serum periostin concentrations and outcomes after severe traumatic brain injury.
Dong XQ; Yu WH; Du Q; Wang H; Zhu Q; Yang DB; Che ZH; Shen YF; Jiang L
Clin Chim Acta; 2017 Aug; 471():298-303. PubMed ID: 28668564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
